You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor Necrosis Factor Inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier

Completed
  • Arthritis Rheumatoid
  • New York, New York
    Pfizer
Jun 8, 2022

Immunogenicity of TNF Inhibitors in Arthritis Poorer Treatment

Recruiting
  • Arthritis, Rheumatoid
  • +2 more
    • Aalborg, Denmark
      Department of rheumatology
    Sep 1, 2022

    Anti-citrullinated Protein Antibody Status on Treatment Response

    Completed
    • Rheumatoid Arthritis
    • Non-Interventional
    • Canberra City, Australia
      (unnamed)
    Feb 22, 2022

    ive Alzheimer's Medicines (DREAM) - TNFi vs Abatacept

    Completed
    • Rheumatoid Arthritis
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Nov 15, 2021

    Janus Kinase Inhibitors Vs Tumor Necrosis Factor Inhibitors in

    Not yet recruiting
    • Rheumatoid Arthritis
    • Observation
    • (no location specified)
    Oct 8, 2022

    HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

    Recruiting
    • Drug Monitoring
    • Inflammatory Bowel Diseases
    • Tumor necrosis factor (TNF)-alpha inhibitors
    • Valladolid, Spain
      Hospital Universitario Rio Hortega
    Aug 8, 2023

    Rheumatoid Arthritis Trial in London (Abatacept Injection, Adalimumab Injection)

    Recruiting
    • Rheumatoid Arthritis
    • Abatacept Injection
    • Adalimumab Injection
    • London, United Kingdom
      Hotung Centre for Musculoskeletal Diseases
    Oct 26, 2020

    Serious Infections in Rheumatoid Arthritis Patients Receiving

    Active, not recruiting
    • Infection
    • Rheumatoid Arthritis
    • Tocilizumab
    • Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab)
    • Suwon, Gyeonggi-do, Korea, Republic of
      Sungkyunkwan University
    Sep 8, 2020

    Acute Gout Trial in Nanchang (rhTNFR-Fc, Triamcinolone Acetonide)

    Not yet recruiting
    • Acute Gout
    • Nanchang, Jiangxi, China
      Department of Rheumatology and Clinical Immunology, Jiangxi Prov
    Jun 28, 2023

    Cardiac Functions in Type 1 Diabetes Mellitus

    Not yet recruiting
    • Diabetes Mellitus, Type 1
    • +2 more
    • transthoracic echocardiography
    • (no location specified)
    Nov 12, 2023

    IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)

    Not yet recruiting
    • Inflammatory Bowel Diseases
    • Biological Substance; Adverse Effect
    • Azithromycin Pill
    • Placebo
    • Haifa, Israel
      Rambam Health Care Campus
    Oct 25, 2022

    Rheumatoid Arthritis Trial in Copenhagen (Exercise, No exercise)

    Recruiting
    • Rheumatoid Arthritis
    • Exercise
    • No exercise
    • Copenhagen, Denmark
      Rigshospitalet
    Feb 3, 2022

    Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant

    Completed
    • Solid Tumor
    • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
    • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
    • (no location specified)
    Jun 8, 2023

    Depressive Disorder, Major, Inflammation Trial (Infliximab, Placebo)

    Not yet recruiting
    • Depressive Disorder, Major
    • Inflammation
    • (no location specified)
    Nov 21, 2023

    Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate

    Not yet recruiting
    • Pleural Effusion, Malignant
    • pleural markers
    • (no location specified)
    Jan 20, 2023

    Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 20, 2023

    Colitis,Ulcerative Trial in Norway (Discontinuation of anti-TNF treatment, Continuation of anti-TNF treatment)

    Active, not recruiting
    • Colitis,Ulcerative
    • Discontinuation of anti-TNF treatment
    • Continuation of anti-TNF treatment
    • Alesund, Norway
    • +18 more
    Jul 13, 2022

    Rheumatoid Arthritis Trial in New York (TNF inhibitors, DMARDs)

    Completed
    Has Results
    • Rheumatoid Arthritis
    • New York, New York
      Columbia University Medical Center
    Nov 4, 2020

    GCF PLAP-1, Sclerostin and TNF-a Levels in Periodontitis

    Completed
    • Periodontitis
    • Periodontal clinical measurements and GCF sampling
    • Aydın, Turkey
      Adnan Menderes University, Faculty of Dentistry, Department of P
    Dec 8, 2022

    Therapeutic Drug Monitoring and Serum TNFa Levels in Pediatric

    Completed
    • Acute Graft-versus-host Disease
      • Trieste, Italy
        IRCCS Burlo Garofolo
      Apr 11, 2023

      HIV Trial in Boston, Cleveland (Pentoxifylline)

      Completed
      • HIV Infections
      • Boston, Massachusetts
      • +1 more
      Oct 26, 2021

      Peritoneal Metastases, Colorectal Cancer Trial in Hangzhou (Hyperthermic intraperitoneal treatment of recombinant modified human

      Recruiting
      • Peritoneal Metastases
      • Colorectal Cancer
      • Hyperthermic intraperitoneal treatment of recombinant modified human tumor necrosis factor (rmhTNF)
      • Hangzhou, Zhejiang, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      Mar 2, 2023

      Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor

      Completed
      • Early Childhood Caries
      • ELISA
      • Aydın, Turkey
        Sultan KELEŞ
      Oct 20, 2021

      Periimplant Soft Tissue Phenotype on Marginal Bone Loss

      Completed
      • Alveolar Bone Loss
      • +2 more
      • Nuclear Factor-Kappa B Ligand (RANKL) analysis
      • +4 more
      • Konya, Turkey
        Necmettin Erbakan University, dentistry Faculty
      Jan 24, 2023

      FSGS, MCD, Focal Segmental Glomerulosclerosis Trial in United States (adalimumab)

      Recruiting
      • FSGS
      • +3 more
      • Ann Arbor, Michigan
      • +3 more
      Jan 31, 2022